bioRxivImmunologyPreprint
Passage of transmissible cancers in the Tasmanian devil is due to a dominant, shared peptide motif and a limited repertoire of MHC-I allotypes
A. Gastaldello, S. H. Ramarathinam, A. Bailey, R. S. Owen, S. C. Turner, N. Kontouli, T. J. Elliott, P. J. S. Skipp, A. W. Purcell, H. V. Siddle
Abstract
Transmissible cancers are spread via the passage of malignant cells. The survival of the Tasmanian devil, the largest marsupial carnivore, is threatened by two independent transmissible cancers, devil facial tumour (DFT) 1 and devil facial tumour 2 (DFT2). To aid the development of a peptide vaccine and to interrogate how histocompatibility barriers can be overcome, we analysed the peptides bound to Major Histocompatibility Complex class I molecules from the Tasmanian devil and its transmissible tumours. Comparison of the peptidomes from DFT1+IFNγ, DFT2 and host fibroblast cells demonstrates a shared motif, despite differences in MHC-I allotypes between the cell lines. Importantly, DFT1+IFNγ and DFT2 share the presentation of peptides derived from neural proteins, reflecting a common cellular origin that should be exploited for vaccine design. These results suggest that some polymorphisms between tumours and host are ‘hidden’ by a common peptide motif, providing the potential for permissive passage of infectious cells.Competing Interest StatementThe authors have declared no competing interest.View Full Text
- organism: non-human primate
- assay: proteomics
- research focus: cell type annotation
- research focus: cell-cell communication
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- CIITA induces expression of MHC-I and MHC-II in transmissible cancers
C. E. B. Ong, Y. Cheng, … A. S. Flies·bioRxiv·Jul 14, 2021
- A human adenovirus encoding IFN-γ can transduce Tasmanian devil facial tumour cells and upregulate MHC-I
A. N. Kayigwe, J. M. Darby, … A. S. Flies·bioRxiv·May 29, 2022
- Automated analysis of PD1 and PDL1 in lymph nodes and the microenvironment of transmissible tumors in Tasmanian devils
G. G. Russell, C. Palmieri, … A. S. Flies·bioRxiv·Oct 31, 2022
- The evolution of two transmissible cancers in Tasmanian devils
M. R. Stammnitz, K. Gori, … E. P. Murchison·bioRxiv·May 27, 2022
- Post release immune responses of Tasmanian devils vaccinated with an experimental devil facial tumour disease vaccine
R. Pye, J. Darby, … A. B. Lyons·bioRxiv·Dec 6, 2020
- NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers
C. E. B. Ong, A. L. Patchett, … A. S. Flies·bioRxiv·Sep 6, 2020